Kamada Ltd.

KMDANASDAQHealthcare● Active

$7.25

+$0.08(+1.12%)

Market Cap$418223906

P/E Ratio—

52W High$9.35

52W Low$6.5

Avg Volume59K

Open$7.35

Beta0.15

SEC Filings

Foreign Private Issuer · Files 20-F / 6-K

Kamada Ltd. (KMDA) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001567529 · KMDA · NASDAQ · as of Jun 8, 2026

Filing snapshot

487

Total Filings

6-K

Latest Form

2026-06-01

Most Recent

2013

Filing Since

Financials Earnings View All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001567529 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY

Filed Date

2026-03-11

Fiscal Year End

Mar 11, 2026

Accession No.

0001213900-26-025934

Primary Document

ea0276358-20f_kamada.htm

View on SEC EDGAR Download PDF Filing Index

Source: data.sec.gov · CIK 0001567529 · Accession 0001213900-26-025934

Latest Key Filings

6-KQuarterly Report

REPORT OF FOREIGN PRIVATE ISSUER

2026-06-01

View 6-K on SEC

8-KCurrent Report

No recent filings

Form 4Insider Activity

Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144

Filed Date

Form Type

Description

View

2026-06-01

6-K

Current Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

0001213900-26-063140

View

6-KCurrent Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

2026-06-01

View

2026-05-13

6-K

Current Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

0001213900-26-055436

View

6-KCurrent Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

2026-05-13

View

2026-05-06

6-K

Current Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

0001213900-26-052530

View

6-KCurrent Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

2026-05-06

View

2026-04-16

Initial Statement of Beneficial Ownership

0001213900-26-044433

View

3Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

2026-04-16

View

2026-04-16

Initial Statement of Beneficial Ownership

0001213900-26-044342

View

3Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

2026-04-16

View

2026-03-31

6-K

Current Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

0001213900-26-036822

View

6-KCurrent Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

2026-03-31

View

2026-03-26

6-K

Current Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

0001213900-26-034342

View

6-KCurrent Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

2026-03-26

View

2026-03-23

Initial Statement of Beneficial Ownership

0001213900-26-032597

View

3Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

2026-03-23

View

2026-03-17

6-K

Current Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

0001213900-26-029047

View

6-KCurrent Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

2026-03-17

View

2026-03-17

Initial Statement of Beneficial Ownership

0001213900-26-028745

View

3Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

2026-03-17

View

2026-03-16

Initial Statement of Beneficial Ownership

0001213900-26-028085

View

3Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

2026-03-16

View

2026-03-16

SCHEDULE 13G/A

0001213900-26-028059

View

SCHEDULE 13G/ASCHEDULE 13G/A

SCHEDULE 13G/A

2026-03-16

View

2026-03-16

Initial Statement of Beneficial Ownership

0001213900-26-027944

View

3Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

2026-03-16

View

2026-03-16

Initial Statement of Beneficial Ownership

0001213900-26-027942

View

3Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

2026-03-16

View

2026-03-16

Initial Statement of Beneficial Ownership

0001213900-26-027940

View

3Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

2026-03-16

View

Showing 1–15 of 470 filingsForm 4 / 144 hidden· 487 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov) | Updated: Hourly | CIK: 0001567529 | Exchange: NASDAQ · Healthcare

Kamada Ltd. (NASDAQ: KMDA) has submitted 487 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2013. As a Healthcare sector company with CIK 0001567529, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Kamada Ltd.'s most comprehensive regulatory disclosure. The most recent Kamada Ltd. 10-K was filed on 2026-03-11 for fiscal year ending 2026. Historical KMDA 10-K annual reports are available from 2013 through 2026.

Investors researching Kamada Ltd. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08

Related Companies SEC Filings — Healthcare

TCMD SEC Filings →XOMA SEC Filings →SLDB SEC Filings →EOLS SEC Filings →PRTC SEC Filings →AUNA SEC Filings →SMLR SEC Filings →RCKT SEC Filings →

→ KMDA Financials → KMDA Earnings → KMDA Insider Trades

Frequently Asked Questions

KMDA SEC Filings · 8 questions

Kamada Ltd. (KMDA) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 487 filings and access original documents at no cost. Kamada Ltd.'s CIK is 0001567529.

KMDA SEC filingsKamada Ltd. SEC documentsfind KMDA 10-K